Alexandria Venture Investments, LLC's Net Worth
Estimate Recalculated Sep 29, 2025 08:01PM EST
Who is Alexandria Venture Investments, LLC
Alexandria Venture Investments, LLC has an estimated net worth of $134 Million. This is based on reported shares across multiple companies, which include Applied Therapeutics, Inc., Vigil Neuroscience, Inc., CONSTELLATION PHARMACEUTICALS INC, Singular Genomics Systems, Inc., Vor Biopharma Inc., Karuna Therapeutics, Inc., IDEAYA Biosciences, Inc., Avidity Biosciences, Inc., Kymera Therapeutics, Inc., Relay Therapeutics, Inc., Silverback Therapeutics, Inc., Metacrine, Inc., Xilio Therapeutics, Inc., NextCure, Inc., Evelo Biosciences, Inc., Arsanis, Inc., Frequency Therapeutics, Inc., IMARA Inc., GreenLight Biosciences Holdings, PBC, and Liquidia Technologies Inc.
SEC CIK
Alexandria Venture Investments, LLC's CIK is 0001722024
Past Insider Trading and Trends
2020 was Alexandria Venture Investments, LLC's most active year for acquiring shares with 7 total transactions. Alexandria Venture Investments, LLC's most active month to acquire stocks was the month of June. 2020 was Alexandria Venture Investments, LLC's most active year for disposing of shares, totalling 16 transactions. Alexandria Venture Investments, LLC's most active month to dispose stocks was the month of April. 2018 saw Alexandria Venture Investments, LLC paying a total of $1,000,005.00 for 810,747 shares, this is the most they've acquired in one year. In 2020 Alexandria Venture Investments, LLC cashed out on 16,158,129 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
